Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 4Withdrawn 2Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Anxiety Disorders 3Pain 2Gastrointestinal Neoplasms 2Depression 2Acute Pain 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Otolaryngeal Cancer 1Mucositis 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1

Interventions

Surveys and Questionnaires 3Methylphenidate 2Methods 2Ketamine 2Interviews as Topic 2Early Intervention, Educational 2Yoga 1Water 1Ultraviolet Therapy 1Standard of Care 1Self-Help Groups 1SLI381 1Radiotherapy 1Psychotherapy 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Melatonin 1Meditation 1Health 1Focus Groups 1Fatty Acids, Omega-3 1Exercise Therapy 1Escitalopram 1Educational Status 1Duloxetine Hydrochloride 1Desvenlafaxine Succinate 1Decision Support Techniques 1Culture Media 1Cognitive Behavioral Therapy 1Caregivers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Depression × Ketamine × Clear all
NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡